Jan 24, 2014 8:20am EST Tonix Pharmaceuticals Prices Underwritten Public Offering Raising $43.5 Million
Dec 10, 2013 8:40am EST Tonix Pharmaceuticals Announces the Enrollment of Completers From the BESTFIT Trial Into a 12-Month Open-Label Extension Study
Oct 24, 2013 8:45am EDT Tonix Pharmaceuticals Partners With the American Chronic Pain Association to Help Raise Awareness About Fibromyalgia
Oct 11, 2013 9:27am EDT Tonix Pharmaceuticals to Participate in the Women's Healthcare Innovation and Leadership Showcase on October 15, 2013
Sep 16, 2013 8:01am EDT Tonix Pharmaceuticals Initiates Enrollment in Phase 2b BESTFIT Trial of TNX-102 SL in Fibromyalgia Patients
Sep 12, 2013 8:00am EDT Tonix Pharmaceuticals to Present at the First Global Life Sciences Conference in Warsaw, Poland on September 17, 2013
